{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670320276506496.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1056/nejmoa1811744"}},{"identifier":{"@type":"URI","@value":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1811744"}}],"dc:title":[{"@value":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670320276506499","@type":"Researcher","foaf:name":[{"@value":"Vlado Perkovic"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506500","@type":"Researcher","foaf:name":[{"@value":"Meg J. Jardine"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506624","@type":"Researcher","foaf:name":[{"@value":"Bruce Neal"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506632","@type":"Researcher","foaf:name":[{"@value":"Severine Bompoint"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506498","@type":"Researcher","foaf:name":[{"@value":"Hiddo J.L. Heerspink"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506501","@type":"Researcher","foaf:name":[{"@value":"David M. Charytan"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506634","@type":"Researcher","foaf:name":[{"@value":"Robert Edwards"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506497","@type":"Researcher","foaf:name":[{"@value":"Rajiv Agarwal"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506630","@type":"Researcher","foaf:name":[{"@value":"George Bakris"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506637","@type":"Researcher","foaf:name":[{"@value":"Scott Bull"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506626","@type":"Researcher","foaf:name":[{"@value":"Christopher P. Cannon"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506503","@type":"Researcher","foaf:name":[{"@value":"George Capuano"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506502","@type":"Researcher","foaf:name":[{"@value":"Pei-Ling Chu"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506636","@type":"Researcher","foaf:name":[{"@value":"Dick de Zeeuw"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506496","@type":"Researcher","foaf:name":[{"@value":"Tom Greene"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506628","@type":"Researcher","foaf:name":[{"@value":"Adeera Levin"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506627","@type":"Researcher","foaf:name":[{"@value":"Carol Pollock"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506638","@type":"Researcher","foaf:name":[{"@value":"David C. Wheeler"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506631","@type":"Researcher","foaf:name":[{"@value":"Yshai Yavin"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506633","@type":"Researcher","foaf:name":[{"@value":"Hong Zhang"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506629","@type":"Researcher","foaf:name":[{"@value":"Bernard Zinman"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506625","@type":"Researcher","foaf:name":[{"@value":"Gary Meininger"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506639","@type":"Researcher","foaf:name":[{"@value":"Barry M. Brenner"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320276506635","@type":"Researcher","foaf:name":[{"@value":"Kenneth W. Mahaffey"}],"jpcoar:affiliationName":[{"@value":"From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) — all in Australia; Imperial College London (B.N.) and the Department of Renal..."}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00284793"},{"@type":"EISSN","@value":"15334406"}],"prism:publicationName":[{"@value":"New England Journal of Medicine"}],"dc:publisher":[{"@value":"Massachusetts Medical Society"}],"prism:publicationDate":"2019-06-13","prism:volume":"380","prism:number":"24","prism:startingPage":"2295","prism:endingPage":"2306"},"reviewed":"false","dc:rights":["http://www.nejmgroup.org/legal/terms-of-use.htm"],"url":[{"@id":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1811744"}],"createdAt":"2019-04-14","modifiedAt":"2024-03-26","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050004225328537984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Classes of Glucose-Lowering Medications on Renal Outcome in Type 2 Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1050016417147946624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Reduction in the magnitude of serum potassium elevation in combination therapy with esaxerenone (CS‐3150) and sodium–glucose cotransporter 2 inhibitor in patients with diabetic kidney disease: Subanalysis of two phase III studies"},{"@value":"Reduction in the Magnitude of Serum Potassium Elevation in Combination Therapy with Esaxerenone (CS-3150) and Sodium-Glucose Cotransporter 2 Inhibitor in Patients with Diabetic Kidney Disease: Subanalysis of Two Phase III Studies"}]},{"@id":"https://cir.nii.ac.jp/crid/1050023186243506816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Dapagliflozin administration to a mouse model of type 2 diabetes induces DNA methylation and gene expression changes in pancreatic islets"}]},{"@id":"https://cir.nii.ac.jp/crid/1050285299951255936","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Randomized trial of an intensified, multifactorial intervention in patients with advanced‐stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT‐Japan)"},{"@value":"Randomized trial of an intensified, multifactorial intervention in patients with advanced-stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan)"}]},{"@id":"https://cir.nii.ac.jp/crid/1050285299984424448","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Failure to confirm a sodium–glucose cotransporter2 inhibitor‐induced hematopoietic effect in non‐diabetic rats with renal anemia"},{"@value":"Failure to confirm a sodium-glucose cotransporter 2 inhibitor-induced hematopoietic effect in non-diabetic rats with renal anemia."}]},{"@id":"https://cir.nii.ac.jp/crid/1050300533203373184","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3)"}]},{"@id":"https://cir.nii.ac.jp/crid/1050301684637257984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"GRP78 Contributes to the Beneficial Effects of SGLT2 Inhibitor on Proximal Tubular Cells in DKD"}]},{"@id":"https://cir.nii.ac.jp/crid/1050302547378277760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Sodium/glucose cotransporter 2 and renoprotection : From the perspective of energy regulation and water conservation"}]},{"@id":"https://cir.nii.ac.jp/crid/1050304482526576896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of canagliflozin on kidney oxygenation evaluated using blood oxygenation level-dependent MRI in patients with type 2 diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1050579753469995648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1050582805574848256","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A novel therapeutic target for kidney diseases: Lessons learned from starvation response"}]},{"@id":"https://cir.nii.ac.jp/crid/1050583790041539072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope"}]},{"@id":"https://cir.nii.ac.jp/crid/1050851275421845120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cardio- and reno-protective effects of dipeptidyl peptidase III in diabetic mice."}]},{"@id":"https://cir.nii.ac.jp/crid/1050856995322057984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Association of type 2 diabetes mellitus with the development of new-onset atrial fibrillation in patients with non-ischemic dilated cardiomyopathy: impact of SGLT2 inhibitors"}]},{"@id":"https://cir.nii.ac.jp/crid/1050871394371354112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Cancer biology in diabetes update: Focusing on antidiabetic drugs"}]},{"@id":"https://cir.nii.ac.jp/crid/1360005519862411648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renoprotective effects of sodium-glucose cotransporter-2 inhibitors and underlying mechanisms"}]},{"@id":"https://cir.nii.ac.jp/crid/1360005521883834624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360005669431560448","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The role of oxidative stress and hypoxia in renal disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142463909888","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142632716800","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142798414592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to beta cell-centric concept of diabetes - an Asian perspective"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142887742080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Sodium-Glucose Co-Transporter 2 Inhibitors Correct Metabolic Maladaptation of Proximal Tubular Epithelial Cells in High-Glucose Conditions"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142905538304","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Relationship between basal sodium intake and the effects of dapagliflozin in albuminuric diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168789766912","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory <i>post hoc</i> analyses from FIDELIO-DKD compared to reported CREDENCE results"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168818265984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168833264896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Empagliflozin ameliorates symptoms of diabetes and renal tubular dysfunction in a rat model of diabetes with enlarged kidney (DEK)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168867193344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renal, cardiovascular and safety outcomes of canagliflozin in patients with type 2 diabetes and nephropathy in East and South‐East Asian countries: Results from the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168882777728","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities: Single-Arm, Exploratory Trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017279853758080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017279863407616","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Nephrons, podocytes and chronic kidney disease: Strategic antihypertensive therapy for renoprotection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017282201616384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Canagliflozin protects the cardiovascular system through effects on the gut environment in non-diabetic nephrectomized rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1360019687863404288","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021389823126528","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021389823135104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of incident hypertension between SGLT2 inhibitors vs. DPP4 inhibitors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021389826423936","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of\n                    <scp>estimated glomerular filtration rate</scp>\n                    change with sodium‐glucose cotransporter‐2 inhibitors versus\n                    <scp>glucagon‐like peptide</scp>\n                    ‐1 receptor agonists among people with diabetes: A propensity‐score matching study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021390747909120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Recent evidence in the etiology and treatment for diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021390761938048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"d-Serine as a sensor and effector of the kidney"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021390768031872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of Effectiveness Among Different Sodium‐Glucose Cotransoporter‐2 Inhibitors According to Underlying Conditions: A Network Meta‐Analysis of Randomized Controlled Trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025429441542912","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025430189383424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effect of finerenone on nephrotic syndrome in patients with diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025430193035008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Liver function effects of <scp>SGLT2</scp> inhibitor and <scp>GLP</scp>‐1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of <scp>RECAP</scp> study)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025430196353408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025430638617472","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes – 2nd edition (English version)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025430654849024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Increasing Prescription of SGLT2 Inhibitors with Expanded Indications to the Elderly Population in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025431112296832","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prevalence of diabetes mellitus and dialysis risk based on annual health checkup frequency among National Health Insurance citizens in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360287144273735808","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360287219285336192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617440067584","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Retrospective Analysis of the Renoprotective Effects of Long-Term Use of Six Types of Sodium–Glucose Cotransporter 2 Inhibitors in Japanese Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617498410112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617529577344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Mitochondrial Dysfunction in Kidney Disease and Uremic Sarcopenia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617557237760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Unexpected Pleiotropic Effects of SGLT2 Inhibitors: Pearls and Pitfalls of This Novel Antidiabetic Class"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617599955328","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617825686784","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Empagliflozin attenuates acute kidney injury after myocardial infarction in diabetic rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617866531456","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Organelle Stress and Crosstalk in Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643722707840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dapagliflozin Inhibits Cell Adhesion to Collagen I and IV and Increases Ectodomain Proteolytic Cleavage of DDR1 by Increasing ADAM10 Activity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643729005696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of effects of SGLT-2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus patients with/without albuminuria: A systematic review and network meta-analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643785153280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643842437248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Sodium–glucose cotransporter 2 inhibitors in type 2 diabetes patients with renal function impairment slow the annual renal function decline, in a real clinical practice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643845904512","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298339714969984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Exploring molecular targets in diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298345006025984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Empagliflozin in Patients with Chronic Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298345006272256","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298345421473664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Kidney outcomes in patients with diabetes mellitus did not differ between individual sodium-glucose cotransporter-2 inhibitors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298754843593600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298755626830080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Impact of sodium‐glucose cotransporter‐2 inhibitors on the risk of hip fracture in older patients in <scp>Japan</scp> using a nationwide administrative claims database: A matched <scp>case–control</scp> study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298757192027648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Sodium-Glucose Cotransporter-2 Inhibitors—Miracle Drugs for the Treatment of Chronic Kidney Disease Irrespective of the Diabetes Status: Lessons from the Dedicated Kidney Disease-Focused CREDENCE and DAPA-CKD Trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298757424393984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Pancreatic β-Cell Mass and Function"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302864793293824","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Glucose‐lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302865548195712","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Stabilization of kidney function and reduction in heart failure events with sodium‐glucose co‐transporter 2 inhibitors: A meta‐analysis and meta‐regression analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302865746892416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306904383008128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Incidence of sodium–glucose cotransporter-2 inhibitor-associated perioperative ketoacidosis in surgical patients: a prospective cohort study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306904414532992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Treatment of chronic kidney disease in older populations"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306905171383808","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Factors affecting the sodium‐glucose cotransporter 2 inhibitors‐related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306905185511680","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Kidney outcomes of SGLT2 inhibitors among older patients with diabetic kidney disease in real-world clinical practice: the Japan Chronic Kidney Disease Database Ex"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306906097873408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Evaluation of glomerular hemodynamic changes by sodium-glucose-transporter 2 inhibition in type 2 diabetic rats using in vivo imaging"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306906102852608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renal outcomes with sodium‐glucose cotransporter 2 inhibitors in Japanese people with grade 3 chronic kidney disease and type 2 diabetes: Analysis of medical administrative databases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360568466625249664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Upregulation of renal Na–K–2Cl cotransporter 2 in obese diabetes mellitus via a vasopressin receptor 2-dependent pathway"}]},{"@id":"https://cir.nii.ac.jp/crid/1360568471539592064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules"}]},{"@id":"https://cir.nii.ac.jp/crid/1360568471852013824","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092416367360","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Sodium–glucose cotransporter-2 inhibitors for diabetic kidney disease: Targeting Warburg effects in proximal tubular cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092417421824","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Significance of Metformin Use in Diabetic Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092422621568","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092687963904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092695721344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Update on diagnosis, pathophysiology, and management of diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092711366912","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118675637760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Differential effect of canagliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor, on slow and fast skeletal muscles from nondiabetic mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118706715904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118718098048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118762540928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Adenosine/adenosine type 1 receptor signaling pathway did not play dominant roles on the influence of sodium–glucose cotransporter 2 inhibitor in the kidney of bovine serum albumin‐overloaded streptozotocin‐induced diabetic mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118817975552","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118823525760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118832913536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Multicentre prospective observational study of sodium-glucose cotransporter-2 inhibitor-associated postoperative ketoacidosis: the SAPKA study protocol"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579820085962368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Albuminuria‐lowering effect of sodium‐glucose cotransporter 2 inhibitors could be partly attributable to the attenuation of tubular damage in type 2 diabetic patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580229805750656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The sodium‐glucose co‐transporter 2 inhibitor tofogliflozin suppresses atherosclerosis through glucose lowering in ApoE‐deficient mice with streptozotocin‐induced diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580229816459520","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The\n                    <scp>CANPIONE</scp>\n                    study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580229819284480","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Possible renoprotective mechanisms of SGLT2 inhibitors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580229824061696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A Narrative Review of Diabetic Kidney Disease: Previous and Current Evidence-Based Therapeutic Approaches"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580230634609024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The renoprotective effect of once‐weekly <scp>GLP</scp>‐1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (<scp>JDDM67</scp>)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584339781398272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Ketone Body Metabolism in Diabetic Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340532317440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340533440640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340698749184","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Water Conservation Overrides Osmotic Diuresis During SGLT2 Inhibition in Patients With Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340710392320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340712436864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Safety and effectiveness of empagliflozin in clinical practice as monotherapy or with other glucose-lowering drugs in Japanese patients with type 2 diabetes: subgroup analysis of a 3-year post-marketing surveillance study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584341827909632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Acetate attenuates kidney fibrosis in an oxidative stress‐dependent manner"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588379381216640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Maintaining kidney health in aging societies: a JSN and ERA call to action"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588381052756352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined\n                    <scp>sodium‐glucose cotransporter‐2</scp>\n                    inhibitor and\n                    <scp>glucagon‐like peptide</scp>\n                    ‐1 receptor agonist treatment in patients with type 2 diabetes and\n                    <scp>chronic kidney disease</scp>"}]},{"@id":"https://cir.nii.ac.jp/crid/1360849946813946624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567663406336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567674531840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Treatment of Diabetic Kidney Disease: Current and Future"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567777578496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Differential effects of sodium-glucose cotransporter 2 inhibitor and low-carbohydrate diet on body composition and metabolic profile in obese diabetic <i>db/db</i> mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593739241472","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Sodium–glucose cotransporter 2 inhibitors and anemia among diabetes patients in real clinical practice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593792766592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Relationship of coffee consumption with a decline in kidney function among patients with type 2 diabetes: The Fukuoka Diabetes Registry"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593815714432","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"SGLT2 inhibition in chronic kidney disease: a preventive strategy against acute kidney injury at the same time?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861286503004544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Analysis of eGFR index category and annual eGFR slope association with adverse clinical outcomes using real-world Japanese data: a retrospective database study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861286530061568","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861705575182464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Proximal tubular epithelia-specific transcriptomics of diabetic mice treated with dapagliflozin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861705599772544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861707354300032","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renoprotective effect of chronic treatment with sodium-glucose cotransporter 2 inhibitors and its associated factors in Japanese patients with chronic heart failure and diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861707370931328","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cardiovascular and kidney outcomes of combination therapy with sodium-glucose cotransporter-2 inhibitors and mineralocorticoid receptor antagonists in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861707377018112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of sodium‐glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and their combination on albuminuria in diabetic patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861707381820800","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"What’s New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865122551103616","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Population characteristics and diagnosis rate of chronic kidney disease by eGFR and proteinuria in Japanese clinical practice: an observational database study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865814755047936","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Sodium-glucose co-transporter 2 inhibitor use in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865816800068096","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Role of Inflammation in Progression of Chronic Kidney Disease in Type 2 Diabetes Mellitus: Clinical Implications"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869854349723392","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Early Clinical Experience of Finerenone in People with Chronic Kidney Disease and Type 2 Diabetes in Japan—A Multi-Cohort Study from the FOUNTAIN (FinerenOne mUltidatabase NeTwork for Evidence generAtIoN) Platform"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869855137386368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869855585243648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Role of Mitochondria in Diabetic Kidney Disease and Potential Therapeutic Targets"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869855592286208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cost-Effectiveness of Empagliflozin in CKD with or without Albuminuria"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869856042991104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Canagliflozin‐induced renal glutathione distribution mapping in non‐diabetic male rat kidneys"}]},{"@id":"https://cir.nii.ac.jp/crid/1361131417003633536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Insulin promotes sodium transport but suppresses gluconeogenesis via distinct cellular pathways in human and rat renal proximal tubules"}]},{"@id":"https://cir.nii.ac.jp/crid/1361131417682893312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study"}]},{"@id":"https://cir.nii.ac.jp/crid/1361412893259816960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1361694370364468224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Influence of an SGLT2 inhibitor, tofogliflozin, on the resting heart rate in relation to adipose tissue insulin resistance"}]},{"@id":"https://cir.nii.ac.jp/crid/1361694371744072576","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cardiac ischemia–reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity"}]},{"@id":"https://cir.nii.ac.jp/crid/1361975846735595520","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Impact of sodium–glucose cotransporter 2 inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease with normoalbuminuria"}]},{"@id":"https://cir.nii.ac.jp/crid/1362257544102379648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Targeting Redox Imbalance as an Approach for Diabetic Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390005822566277376","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"1) Impacts of Anti-diabetic Drugs on Protection from Cardiovascular and Renal Diseases in Patients with Diabetes"},{"@language":"ja","@value":"1）糖尿病治療薬の心/腎保護効果"},{"@value":"糖尿病治療薬の心/腎保護効果"},{"@language":"ja-Kana","@value":"トウニョウビョウ チリョウヤク ノ ココロ/ジンホゴ コウカ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390008697838432512","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Sirt7 Deficiency Attenuates Neointimal Formation Following Vascular Injury by Modulating Vascular Smooth Muscle Cell Proliferation"},{"@value":"Sirtuin-7 as a Novel Therapeutic Target in Vascular Smooth Muscle Cell Proliferation and Remodeling"}]},{"@id":"https://cir.nii.ac.jp/crid/1390010292568882944","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The cardiovascular outcomes of finerenone in patients with chronic kidney disease and type 2 diabetes: A meta-analysis of randomized clinical trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1390011108727442048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Capillaries as a Therapeutic Target for Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390011793672082944","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The Role of SGLT2 Inhibitor Ipragliflozin on Cardiac Hypertrophy and microRNA Expression Profiles in a Non-diabetic Rat Model of Cardiomyopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390013795251384960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Nephroprotective Effects of Dapagliflozin in Patients with Type 2 Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1390013939079869824","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Paradigm sift of the medical care in diabetes"},{"@language":"ja","@value":"糖尿病薬物治療の新展開"}]},{"@id":"https://cir.nii.ac.jp/crid/1390014128337728768","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Safety of SGLT2 Inhibitors in Three Chronic Diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1390017345597666304","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Impact of Dapagliflozin on the Renal Function and Damage in Patients with Heart Failure with a Reduced Ejection Fraction"}]},{"@id":"https://cir.nii.ac.jp/crid/1390017965043336704","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"1. Diagnosis and Therapy for Diabetic Kidney Disease-up to Date"},{"@language":"ja","@value":"1．糖尿病性腎臓病の診断と治療のアップデート"}]},{"@id":"https://cir.nii.ac.jp/crid/1390019977295886336","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"5. Progress in Treatment of Kidney Diseases"},{"@language":"ja","@value":"5）腎疾患の治療の進歩"}]},{"@id":"https://cir.nii.ac.jp/crid/1390283659839107712","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Glycemic Control in Elderly Patients with Type 2 Diabetes Mellitus: The Importance of Preventing Hypoglycemia Especially in Patients with Chronic Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390283659839128576","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Essential Points of Treatment and Examination to Prevent Diabetic Kidney Disease Aggravation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390285300160246528","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Relation between HOMA-IR and insulin sensitivity index determined by hyperinsulinemic-euglycemic clamp analysis during treatment with a sodium-glucose cotransporter 2 inhibitor"}]},{"@id":"https://cir.nii.ac.jp/crid/1390285300180135040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Paradigm Shift in the Treatment of Type 2 Diabetes and Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390287297542989952","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"3. Diabetic Kidney Disease; Concept and Treatment Strategy"},{"@language":"ja","@value":"3．Diabetic Kidney Disease～新しい概念とその治療戦略～"},{"@value":"Diabetic Kidney Disease : 新しい概念とその治療戦略"},{"@language":"ja-Kana","@value":"Diabetic Kidney Disease : アタラシイ ガイネン ト ソノ チリョウ センリャク"}]},{"@id":"https://cir.nii.ac.jp/crid/1390288215573624320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Regional Distribution of Cardiologists and Prescription Patterns of Sodium-Glucose Transporter-2 Inhibitors in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1390289486946518528","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Impact of Chronic Kidney Disease on In-Hospital and 3-Year Clinical Outcomes in Patients With Acute Myocardial Infarction Treated by Contemporary Percutaneous Coronary Intervention and Optimal Medical Therapy　― Insights From the J-MINUET Study ―"},{"@value":"Management of Patients With Advanced Chronic Kidney Disease and Preexisting Acute Myocardial Infarction"}]},{"@id":"https://cir.nii.ac.jp/crid/1390290172818748160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure"},{"@value":"Guideline focused update on diagnosis and treatment of acute and chronic heart failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390290929774333056","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Significance of Glycemic Variability in Diabetes Mellitus"}]},{"@id":"https://cir.nii.ac.jp/crid/1390291767593603840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"2. Clinical Pathophysiology and Treatment in Patients with Diabetic Kidney Disease and Nephrosclerosis"},{"@language":"ja","@value":"2．糖尿病性腎臓病・腎硬化症の病態と診療"}]},{"@id":"https://cir.nii.ac.jp/crid/1390294208468513408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Cost-Effectiveness of Dapagliflozin for Chronic Kidney Disease in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1390294507109728640","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Mechanisms of GLP‒1 Receptor Agonists on the Cardio-Renal Protective Effects"},{"@language":"ja","@value":"GLP‒1 受容体作動薬の心・腎保護作用とその想定機序"}]},{"@id":"https://cir.nii.ac.jp/crid/1390301452272606720","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"6. The Progress in the Therapy for Diabetic Kidney Disease"},{"@language":"ja","@value":"6）糖尿病性腎臓病の治療の進歩"}]},{"@id":"https://cir.nii.ac.jp/crid/1390304661214043776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Investigation of the Effect of Empagliflozin on Cardiac Sympathetic and Parasympathetic Nerve Activity Analyzed From Heart Rate Variability Frequency in Japanese Patients With Type 2 Diabetes　― Results From the EMPYREAN Study ―"}]},{"@id":"https://cir.nii.ac.jp/crid/1390565134815515520","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical Considerations When Introducing Sodium-Glucose Co-Transporter 2 Inhibition in Patients With Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390568617216655744","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"III. Treatment of Heart Failure; 3. Novel Topics of Pharmacological Therapy for Chronic Heart Failure"},{"@language":"ja","@value":"III．心不全の治療　3．慢性心不全薬物治療の新しいトピックス"},{"@value":"慢性心不全薬物治療の新しいトピックス"},{"@language":"ja-Kana","@value":"マンセイ シンフゼン ヤクブツ チリョウ ノ アタラシイ トピックス"}]},{"@id":"https://cir.nii.ac.jp/crid/1390570465069315200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effect of the Sodium-Glucose Cotransporter 2 Inhibitor Canagliflozin for Heart Failure With Preserved Ejection Fraction in Patients With Type 2 Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1390574411905564032","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Signal Detection of Acute Renal Failure Following the Use of SGLT-2 Inhibitors: Stratified Analysis and Time Trend Analysis in Japan and the United States"}]},{"@id":"https://cir.nii.ac.jp/crid/1390575904638867072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Usefulness of Dapagliflozin for Nephrotic Syndrome Secondary to Diabetic Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390578680540091776","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"My Career Development as a Physician-Scientist"},{"@language":"ja","@value":"私の Physician-Scientist としてのキャリア形成"}]},{"@id":"https://cir.nii.ac.jp/crid/1390578747091917696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Deciphering Rho-associated, coiled-coil-containing protein kinase in diabetic nephropathy: small steps towards a giant leap"}]},{"@id":"https://cir.nii.ac.jp/crid/1390584276612138496","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Induction of Severe Initial Dip in Estimated Glomerular Filtration Rate by Sodium–Glucose Cotransporter 2 Inhibitors and Baseline Hemodynamics"}]},{"@id":"https://cir.nii.ac.jp/crid/1390584320869696128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Long-term renoprotective effect of luseogliflozin in type 2 diabetes patients: CHikushi Anti-diabetes mellitus Trial-Lusefi (CHAT-Lu)"}]},{"@id":"https://cir.nii.ac.jp/crid/1390585636769102464","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"I．心不全合併腎障害の診療"},{"@language":"en","@value":"I. Management of Kidney Disease Complicated with Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390850475730412160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of intensive exercise combined with dapagliflozin on body composition in patients with type 2 diabetes: a randomized controlled trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1390851817141733120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Efficacy of Continuing SGLT2 Inhibitors on Outcomes in Patients with Acute Decompensated Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390853343594606336","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Why do SGLT2 Inhibitors Act as Cardio-renal Protective even in Non-diabetics?"},{"@language":"ja","@value":"SGLT2 阻害薬はなぜ非糖尿病患者においても心・腎保護的か？"}]},{"@id":"https://cir.nii.ac.jp/crid/1390856893076131200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Tubulointerstitial Nephritis after Using a Sodium-glucose Cotransporter 2 Inhibitor"}]},{"@id":"https://cir.nii.ac.jp/crid/1390863041926471936","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"I. Sglt2 Inhibitors as Chronic Kidney Disease Therapeutics and Future Prospects"},{"@language":"ja","@value":"I．慢性腎臓病治療薬としての Sglt2阻害薬と今後の展望"}]},{"@id":"https://cir.nii.ac.jp/crid/1390863329503320320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022"},{"@value":"Japan Atherosclerosis Society(JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Disease 2022"}]},{"@id":"https://cir.nii.ac.jp/crid/1390864402226001536","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Diverse Clinical Effects of SGLT2 Inhibitor: Case Presentation and Literature Mini-review"},{"@language":"ja","@value":"SGLT2阻害薬の多種多様な臨床効果：症例提示と文献的知見"}]},{"@id":"https://cir.nii.ac.jp/crid/1390865643808361600","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Conceptualizing Treatment Strategies for Diabetic Kidney Disease: the          Importance of Early Diagnosis and Treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1390866979074541824","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Comprehensive Analysis of Diabetic Complications and Advances in Management Strategies"}]},{"@id":"https://cir.nii.ac.jp/crid/1391693801395317632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administration"}]},{"@id":"https://cir.nii.ac.jp/crid/1520301297457465088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A consensus statement from the Japan Diabetes Society (JDS) : a proposed algorithm for pharmacotherapy in people with type 2 diabetes : 2nd Edition (English version)"}]},{"@id":"https://cir.nii.ac.jp/crid/1521136281246058112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Two‑year administration of sodium‑glucose co‑transporter 2 inhibitor brought about marked reduction of body fat independent of skeletal muscle amount or glycemic improvement in Japanese patients with type 2 diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/2051151842058020480","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of LDL apheresis on proteinuria in patients with diabetes mellitus, severe proteinuria, and dyslipidemia"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1056/nejmoa1811744"},{"@type":"CROSSREF","@value":"10.1097/mnh.0000000000000561_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/jdi.13205_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1186/s12933-019-0977-z_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.23876/j.krcp.19.063_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.kint.2019.08.021_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1536/ihj.20-716_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.5551/jat.rv17042_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.8424-21_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3389/fphar.2020.00967_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/s2213-8587(20)30300-4_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1080/14656566.2020.1776262_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1007/s10554-020-02122-x_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3390/ijms21207676_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.5582/irdr.2020.01008_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1093/ndt/gfab336_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.cmet.2021.04.004_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0251135_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/jdi.13624_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1007/s13300-021-01047-5_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2169/naika.110.505_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2169/naika.109.215_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.5551/jat.rv17064_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1002/dmrr.3327_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1186/s12933-022-01508-6_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1038/s41440-022-01061-5_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1007/s10157-022-02312-y_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2169/naika.112.1535_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2169/naika.112.1680_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1038/s41440-023-01464-y_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1038/s41440-024-01649-z_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/dom.15561_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/jdi.13433_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3390/ijms21144939_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.pharmthera.2024.108590_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1007/s10157-023-02384-4_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1161/jaha.123.031805_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1093/ndt/gfae032_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.kint.2024.08.019_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.bbrc.2024.150254_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.metop.2024.100294_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/jdi.70066_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.34067/kid.0000000000000468_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/jdi.14202_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1159/000545626_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1186/s12889-025-22403-1_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3390/ijms20143393_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3390/ijms21061907_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1536/ihj.21-022_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1253/circrep.cr-21-0030_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1089/dia.2020.0165_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1681/asn.2020050723_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3389/fphys.2020.565023_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3390/ijms22063062_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1038/s41581-020-00350-x_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1038/s41598-020-64380-y_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.34067/kid.0002442020_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3999/jscpt.52.157_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3390/molecules25030495_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.diabres.2021.109146_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.diabres.2022.109231_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/jdi.13502_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1007/s11892-021-01390-8_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2169/naika.109.419_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2169/naika.109.526_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/jdi.13769_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.23876/j.krcp.21.251_references_DOI_Y55sXfldvZqIDwFcxlg3lspuKW"},{"@type":"CROSSREF","@value":"10.1093/ndt/gfac242_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/ggi.14591_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.5551/jat.gl2022_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1007/s13340-021-00512-7_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3390/ijms232213749_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3390/ijms23095104_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1007/s13340-022-00605-x_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2169/naika.112.432_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.5649/jjphcs.49.321_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.5582/ddt.2024.01086_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/dme.15200_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/dom.15122_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1038/s41598-024-55827-7_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1186/s12933-023-01928-y_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.5551/jat.65551_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.5649/jjphcs.50.440_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-24-0799_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1007/s00540-024-03335-3_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1007/s13340-024-00723-8_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1038/s41581-024-00854-w_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/dom.15611_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1136/bmjdrc-2024-004115_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1007/s10157-020-01959-9_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.kint.2024.05.006_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/dom.15461_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1172/jci.insight.129034_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1186/s13098-019-0454-6_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-21-0137_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-21-0394_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.diabet.2020.06.005_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3390/ijms21124239_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1177/1479164121990533_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1056/nejmoa2025845_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/nep.13860_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2337/dc20-1402_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1042/bcj20210700_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2337/dc21-1081_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1136/bmjdrc-2021-002311_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.cardfail.2021.04.023_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3390/jcm11010137_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1093/ije/dyab203_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1136/bmjopen-2021-049592_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1248/bpb.b22-00289_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-22-0086_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1038/s41598-020-79687-z_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/jdi.13778_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.6685-20_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.1506-22_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.9121-21_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1002/prp2.971_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/dom.14731_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/jdi.13960_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3389/fmed.2023.1115413_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1007/s12325-022-02223-0_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/jdi.13877_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1186/s12933-023-01773-z_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2337/db23-0581_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.34067/kid.0000000000000359_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/jdi.14152_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1177/14791641231222837_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3389/fphar.2024.1358573_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.jacc.2024.02.020_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/s2213-8587(23)00322-4_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1080/14740338.2023.2213477_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.14814/phy2.15774_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2169/naika.113.766_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1093/ndt/gfaf068_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/dom.15652_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1507/endocrj.ej19-0445_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1186/s12933-019-0912-3_references_DOI_Y55sXfldvZqIDwFcxlg3lspuKW"},{"@type":"CROSSREF","@value":"10.1016/s2213-8587(19)30384-5_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1507/endocrj.ej20-0599_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1253/circrep.cr-19-0080_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-21-0431_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1007/s13340-020-00444-8_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/jdi.13339_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.4093/dmj.2020.0217_references_DOI_Y55sXfldvZqIDwFcxlg3lspuKW"},{"@type":"CROSSREF","@value":"10.1136/bmjdrc-2020-001303_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.jphs.2021.07.006_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/jdi.13717_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.jbc.2021.100761_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.kint.2021.10.013_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.9011-21_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3999/jscpt.53.6_249_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1136/bmjopen-2021-052246_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1272/manms.19.32_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.jdiacomp.2022.108312_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1507/endocrj.ej23-0282_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1248/bpb.b22-00034_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1536/ihj.22-441_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.4264/numa.82.3_185_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/jdi.13760_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1056/nejmoa2204233_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.heliyon.2022.e10615_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1681/asn.2022030306_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.kint.2022.05.031_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.ijcha.2022.101152_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.diabres.2022.110161_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/dom.14976_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3390/ijms24010570_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2169/naika.112.761_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1186/s12933-023-01992-4_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.semnephrol.2023.151431_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.14789/ejmj.jmj24-0031-p_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3389/fendo.2024.1451671_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3390/jcm13175107_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1136/bmjdrc-2024-004237_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1038/s41572-024-00589-9_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.ekir.2024.10.035_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.2215/cjn.0000000582_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.14814/phy2.70320_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1507/endocrj.ej20-0222_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1038/s41598-019-51343-1_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.14789/jmj.2019.65.jmj19-r21_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.bbrc.2020.01.142_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1111/dme.14279_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1186/s12933-019-0889-y_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.14789/jmj.2019.65.jmj19-r17_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1186/s13098-020-0516-9_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.3390/biomedicines8020040_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"},{"@type":"CROSSREF","@value":"10.1016/j.mayocp.2019.12.004_references_DOI_aQwUCZ1s3jMU1WwR4x4mrVKBxnA"}]}